The CDK-PLK1 axis targets the DNA damage checkpoint sensor protein RAD9 to promote cell proliferation and tolerance to genotoxic stress.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29254517.
- Also identified by DOI 10.7554/eLife.29953 and PMC identifier 5736350.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Genotoxic stress causes proliferating cells to activate the DNA damage checkpoint, to assist DNA damage recovery by slowing cell cycle progression. Thus, to drive proliferation, cells must tolerate DNA damage and suppress the checkpoint response. However, the mechanism underlying this negative regulation of checkpoint activation is still elusive. We show that human <i>C</i>yclin-<i>D</i>ependent-<i>K</i>inases (CDKs) target the RAD9 subunit of the 9-1-1 checkpoint clamp on Thr292, to modulate DNA damage checkpoint activation. Thr292 phosphorylation on RAD9 creates a binding site for <i>P</i>olo-<i>L</i>ike-<i>K</i>inase1 (PLK1), which phosphorylates RAD9 on Thr313. These CDK-PLK1-dependent phosphorylations of RAD9 suppress checkpoint activation, therefore maintaining high DNA synthesis rates during DNA replication stress. Our results suggest that CDK locally initiates a PLK1-dependent signaling response that antagonizes the ability of the DNA damage checkpoint to detect DNA damage. These findings provide a mechanism for the suppression of DNA damage checkpoint signaling, to promote cell proliferation under genotoxic stress conditions.
Medical subject headings
- Cell Cycle Proteins
- Cell Proliferation
- Cyclin-Dependent Kinase 2
- DNA Damage
- Mutagens
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins
- Stress, Physiological